Abstract
Abstract
The full text of this preprint has been withdrawn by the authors while they make corrections to the work. Therefore, the authors do not wish this work to be cited as a reference. Questions should be directed to the corresponding author.
Publisher
Research Square Platform LLC
Reference50 articles.
1. Potential and Limits of Cannabinoids in Alzheimer's Disease Therapy;Abate G;Biology (Basel),2021
2. Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging;Albayram O;Proc Natl Acad Sci U S A,2011
3. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association;Altman R;Arthritis And Rheumatism,1986
4. Association of hippocampal volume with gait variability in pre-dementia and dementia stages of Alzheimer disease: Results from a cross-sectional study;Beauchet O;Experimental Gerontology,2019
5. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee;Bellamy N;Journal Of Rheumatology,1988